Delivery Order SPE2DB24D2205-SPE2DB25FEGXN
Award Date 8/28/25
Potential Completion Date 9/19/25
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ryanodex 250 mg vials valued at $9,632.64. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- The U.S. Defense Medical Supply Chain awarded a $52,979.52 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ryanodex 250mg vials. This firm fixed-price delivery order is set to conclude on August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,816.32 by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, for the supply of Ryanodex 250mg vials. This firm fixed-price, non-set-aside contract is scheduled for completion by August 13, 2025, with performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical vendor supporting...
- The Defense Logistics Agency awarded a $1,605.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ryanodex 250 mg vials. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 26, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ryanodex 250mg vials with a firm fixed price ceiling value of $57,795.84 and an ultimate completion date of August 18, 2025. This is a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 250 mg vials of Ryanodex, a pharmaceutical product used in acute care and anesthesia settings. This $1,605.44 firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 19, 2025. The contract represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order is a child...
- This is a $4,468.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 250mg vials of the pharmaceutical product Ryanodex, with a period of performance through October 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply medical commodities and prescription drugs to various military treatment facilities, veterans'...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ryanodex 250 mg vials. The delivery order, valued at $4,468.92, has a firm fixed price and an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor to the U.S. Department of Defense, delivering a wide range...
- This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of Ryanodex 250 mg vials, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award has a ceiling value of $5,958.56 and an ultimate completion date of October 8, 2024. This contract is not set aside for any specific business type. AmerisourceBergen, as a...
- This federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and the pharmaceutical distributor Amerisourcebergen Drug Corp. The $8,937.84 firm fixed-price delivery order is for the supply of RYANODEX 250MG VIAL 1S, a specialty pharmaceutical product. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...